A new study reports that treatment with the experimental antibody “cocktail” known as ZMapp resulted in recovery in 100% of the 18 rhesus macaques treated with the drug, even when initiated up to five days after infection. This experimental therapy still requires safety testing in humans, but these results indicate that it could be a promising option for the treatment of Ebola virus infection.
The tests were carried out at the National Microbiology Laboratory in Winnipeg, part of the Public Health Agency of Canada. Lead authors Xiangguo Qiu and Gary Kobinger gave an embargoed press conference by phone earlier today.
Original research paper published in the journal Nature on August 29, 2014.
